References
- Pimpin L, Cortez-Pinto H, Negro F, et al. Burden of liver disease in Europe: epidemiology and analysis of risk factors to identify prevention policies. J Hepatol. 2018;69(3):718–735.
- Huang X, Liu X, Yu Y. Depression and chronic liver diseases: are there shared underlying mechanisms? Front Mol Neurosci. 2017;10:134.
- Hsu JH, Chien IC, Lin CH. Increased risk of chronic liver disease in patients with major depressive disorder: a population-based study. J Affect Disord. 2019;251:180–185.
- Slack AJ, Auzinger G, Willars C, et al. Ammonia clearance with haemofiltration in adults with liver disease. Liver Int. 2014;34(1):42–48.
- Niknahad H, Jamshidzadeh A, Heidari R, et al. Ammonia-induced mitochondrial dysfunction and energy metabolism disturbances in isolated brain and liver mitochondria, and the effect of taurine administration: relevance to hepatic encephalopathy treatment. Clin Exp Hepatol. 2017;3(3):141–151.
- Lu L, Wu C, Lu BJ, et al. Babaodan cures hepatic encephalopathy by decreasing ammonia levels and alleviating inflammation. J Ethnopharmacol. 2020;249:112301.
- Wang W, Lu H, Lu X, et al. Effect of tumor necrosis factor-α on the expression of the ammonia transporter Rhcg in the brain in mice with acute liver failure. J Neuroinflamm. 2018;15(1):234.
- Costantini D. Understanding diversity in oxidative status and oxidative stress: the opportunities and challenges ahead. J Exp Biol. 2019;222(13):jeb194688.
- Liu T, Zhong S, Liao X, et al. A meta-analysis of oxidative stress markers in depression. PLoS One. 2015;10(10):e0138904.
- Bouvier E, Brouillard F, Molet J, et al. Nrf2-dependent persistent oxidative stress results in stress-induced vulnerability to depression. Mol Psychiatry. 2017;22(12):1701–1713.
- Lindqvist D, Dhabhar FS, James SJ, et al. Oxidative stress, inflammation and treatment response in major depression. Psychoneuroendocrinology. 2017;76:197–205.
- Kohler O, Krogh J, Mors O, et al. Inflammation in depression and the potential for anti-inflammatory treatment. Curr Neuropharmacol. 2016;14(7):732–742.
- Zhao G, Liu X. Neuroimmune advance in depressive disorder. Adv Exp Med Biol. 2019;1180:85–98.
- A N, M Z-S, J B, et al. Schisandra chinensis potential of (Turcz.) Baill. in human health and nutrition: a review of current knowledge and therapeutic perspectives. Nutrients. 2019;11(2):333.
- Hu D, Cao Y, He R, et al. Schizandrin, an antioxidant lignan from Schisandra chinensis, ameliorates Aβ1-42-induced memory impairment in mice. Oxid Med Cell Longev. 2012;2012:721721–721727.
- Wan S, Xu M, Hu L, et al. Schisandrin rescues depressive-like behaviors induced by chronic unpredictable mild stress via GDNF/ERK1/2/ROS and PI3K/AKT/NOX signaling pathways in mice. Psychiatry Res. 2017;257:230–237.
- Yan T, Sun Y, Gong G, et al. The neuroprotective effect of schisandrol A on 6-OHDA-induced PD mice may be related to PI3K/AKT and IKK/IκBα/NF-κB pathway. Exp Gerontol. 2019;128:110743.
- Ganai AA, Husain M. Genistein attenuates d-GalN induced liver fibrosis/chronic liver damage in rats by blocking the TGF-β/Smad signaling pathways. Chem Biol Interact. 2017;261:80–85.
- Xu LQ, Xie YL, Gui SH, et al. Polydatin attenuates d-galactose-induced liver and brain damage through its anti-oxidative, anti-inflammatory and anti-apoptotic effects in mice. Food Funct. 2016;7(11):4545–4555.
- Kuniishi H, Ichisaka S, Yamamoto M, et al. Early deprivation increases high-leaning behavior, a novel anxiety-like behavior, in the open field test in rats. Neurosci Res. 2017;123:27–35.
- Towell A, Muscat R, Willner P. Effects of pimozide on sucrose consumption and preference. Psychopharmacology (Berl). 1987;92(2):262–264.
- Cryan JF, Mombereau C, Vassout A. The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neurosci Biobehav Rev. 2005;29(4–5):571–625.
- Sabedra Sousa FS, Birmann PT, Bampi SR, et al. Lipopolysaccharide-induced depressive-like, anxiogenic-like and hyperalgesic behavior is attenuated by acute administration of α-(phenylselanyl) acetophenone in mice. Neuropharmacology. 2019;146:128–137.
- Blasco-Serra A, Gonzalez-Soler EM, Cervera-Ferri A, et al. A standardization of the novelty-suppressed feeding test protocol in rats. Neurosci Lett. 2017;658:73–78.
- Mm M. Intra-accumbal orexin-1 receptor inhibition prevents the anxiolytic-like effect of ethanol and leads to increases in orexin-A content and receptor expression. Pharmacol Biochem Behav. 2019;10:172761.
- Kind PR, King EJ. Estimation of plasma phosphatase by determination of hydrolysed phenol with amino-antipyrine. J Clin Pathol. 1954;7(4):322–326.
- Duan Y, Wu X, Liang S, et al. Elevated blood ammonia level is a potential biological risk factor of behavioral disorders in prisoners. Behav Neurol. 2015;2015:797862.
- El-Latif El-Ghazaly MA, Rashed ER, Shafey GM, et al. Amelioration of thioacetamide-induced hepatic encephalopathy in rats by low-dose gamma irradiation. Environ Sci Pollut Res Int. 2020;27(1):334–343.
- Roy A, Verma N, Ahuja CK. Intracranial invasive mycosis mimicking hepatic encephalopathy in a patient with cirrhosis. BMJ Case Rep. 2019;12(11):e231548.
- Mader EC Jr., Ramos AB, Cruz RA, et al. Full recovery from cocaine-induced toxic leukoencephalopathy: emphasizing the role of neuroinflammation and brain edema. J Investig Med High Impact Case Rep. 2019;7:2324709619868266.
- Fu S, Li Z, Xiao L, et al. Glutamine synthetase promotes radiation resistance via facilitating nucleotide metabolism and subsequent DNA damage repair. Cell Rep. 2019;28(5):1136–1143.e4.
- Wang W, Li X, Xu J. Magnesium isoglycyrrhizinate attenuates d-galactosamine/lipopolysaccharides induced acute liver injury of rat via regulation of the p38-MAPK and NF-κB signaling pathways. Immunopharmacol Immunotoxicol. 2018;40(3):262–267.
- Zhang L, Zhang W, Zheng B, et al. Sinomenine attenuates traumatic spinal cord injury by suppressing oxidative stress and inflammation via Nrf2 pathway. Neurochem Res. 2019;44(4):763–775.
- Kosuru R, Kandula V, Rai U, et al. Pterostilbene decreases cardiac oxidative stress and inflammation via activation of AMPK/Nrf2/HO-1 pathway in fructose-fed diabetic rats. Cardiovasc Drug Ther. 2018;32(2):147–163.
- Kaufmann FN, Costa AP, Ghisleni G, et al. NLRP3 inflammasome-driven pathways in depression: clinical and preclinical findings. Brain Behav Immun. 2017;64:367–383.
- Dai H, Jia G, Wang W, et al. Genistein inhibited ammonia induced astrocyte swelling by inhibiting NF-κB activation-mediated nitric oxide formation. Metab Brain Dis. 2017;32(3):841–848.
- Stein DJ, Naudé PJ, Berk M. Stress, depression, and inflammation: molecular and microglial mechanisms. Biol Psychiatry. 2018;83(1):5–6.
- Yirmiya R, Rimmerman N, Reshef R. Depression as a microglial disease. Trends Neurosci. 2015;38(10):637–658.